Ozempic Weekly Injection
  1. Home
  2. Ozempic
  3. Ozempic Weekly Injection

Ozempic Weekly Injection

Ozempic Weekly Injection is a prescription GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes when combined with diet and exercise. It is administered once weekly by subcutaneous injection using a prefilled pen. The long-acting formulation provides convenient and consistent glycemic management with weekly dosing.

BUY NOW

Category

Ozempic Weekly Injection contains semaglutide, a GLP-1 receptor agonist that helps regulate blood glucose by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The once-weekly injectable formulation offers sustained therapeutic activity and supports long-term diabetes management with convenient dosing. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled injection pen is engineered for precise subcutaneous administration and dependable clinical performance. Ozempic Weekly Injection should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Ozempic Weekly Injection
Active Ingredient Semaglutide
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency Once Weekly
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Ozempic Weekly Injection, Ozempic Injection Pen, Semaglutide Weekly Injection, Weekly GLP-1 Injection, Ozempic Prefilled Pen, Diabetes Injection Pen, Semaglutide Injectable Pen